Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome

Схожие документы

• Mutation Clearance after Transplantation for Myelodysplastic Syndrome
  по: Duncavage, Eric J., et al.
  Опубликовано: (2018)
• Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
  по: Jacoby, Meagan A., et al.
  Опубликовано: (2018)
• TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
  по: Welch, John S., et al.
  Опубликовано: (2016)
• Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
  по: Uy, Geoffrey L., et al.
  Опубликовано: (2016)
• Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes
  по: Walter, Matthew J., et al.
  Опубликовано: (2011)